Killer immune cells destroy cancer cells and cells infected by virus. These CD8+ T cells are activated after detection of ...

Most long-COVID care in B.C. is currently delivered through large online group telehealth sessions from the Bowen ...

The research suggests common respiratory infections, such as the flu or COVID, are capable of stirring dormant cancer cells ...

A new $100 million pilot program launched by the Department of Health and Human Services (HHS) offers state and ...

The virus causes liver cancer (hepatocellular carcinoma, HCC) through cell damage that alters cell growth patterns and ...

This recent study highlights just how great of an affect viral infections can have on our health in both the short-term and ...

However, Stringer and a team of scientists believe they’re on the precipice of identifying a potential long COVID biomarker.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.

On track for proof-of-concept Phase 1b data no later than this fall in participants with recurrent genital herpes for long-acting herpes simplex virus (HSV) helicase-primase inhibitor candidates, ...

Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

Bhubaneswar: Hospitals and clinics are witnessing an increased number of patients suffering from viral fever with doctors ...